A landmark study published in The New England Journal of Medicine reveals that a single oral dose of baloxavir marboxil (baloxavir) significantly reduces the transmission of influenza within households, marking a major advancement in influenza management. Conducted by an international team of researchers including the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), the CENTERSTONE trial provides the first robust evidence that an antiviral treatment can curb the spread of…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply